The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke …

Background and Purpose—Angioplasty and stenting is increasingly being used for the
treatment of intracranial stenoses. Based on a literature search (01/1998 to 04/2008) we …

PURPOSE: Two of three patients with vertebrobasilar stroke harbor a stenosis of the
vertebral or basilar arteries. The best treatment for secondary prophylaxis in vertebrobasilar …

Background: The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial showed
that patients with symptomatic 70% to 99% intracranial arterial stenosis are at particularly …

Background and Purpose—Medical treatment of symptomatic intracranial stenosis carries a
high risk of stroke. This study was done to evaluate the clinical and angiographic outcomes …

Background: There are limited data on the relationship between patient and site
characteristics and clinical outcomes after intracranial stenting. Methods: We performed a …

Intracranial stenosis is a common cause of ischaemic strokes, in particular, in the Asian,
African and Hispanic populations. The randomised multicentre study Stenting and …

Background and Purpose—Reliable data concerning prognosis of patients with intracranial
in-stent restenosis (ISR) is lacking. We prospectively studied long-term outcomes of patients …

Objective: To study the frequency, clinical course, and functional outcome of perforator
stroke (PS) resulting from elective stenting of symptomatic intracranial stenosis. Methods …

Atherosclerotic disease of the major intracranial arteries is a frequent cause of stroke. In
addition, many patients who have symptomatic intracranial stenosis are at very high risk for …